NME9 Antikörper (C-Term)
Kurzübersicht für NME9 Antikörper (C-Term) (ABIN263201)
Target
Alle NME9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Bindungsspezifität
- C-Term
-
Verwendungszweck
- TXL2 / TXNDC6
-
Sequenz
- ESSTQPRLKI TDLD
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Western Blot: Approx 38 kDa band observed in Human Uterus lysates (calculated MW of 29.7 kDa according to NP_835231.1). The observed molecular weight corresponds to earlier findings in literature with different antibodies (Sadek et al, J Biol Chem. 2003 Ap
Peptide ELISA: antibody detection limit dilution 1:8000.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Minimize freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
- NME9 (NME Gene Family Member 9 (NME9))
-
Andere Bezeichnung
- TXNDC6
-
Hintergrund
- TXNDC6, TXL2, thioredoxin domain containing 6 , MGC129586, TXL-2, thioredoxin-like 2
-
Gen-ID
- 347736
-
NCBI Accession
- NP_835231
-
Pathways
- Ribonucleoside Biosynthetic Process, Cell RedoxHomeostasis
Target
-